New thiochromane derivatives and their use as thrombin inhibitors

Details for Australian Patent Application No. 2001256931 (hide)

Owner AstraZeneca AB

Inventors Sunden, Gunnel; Nystrom, Jan-Erik; Linschoten, Marcel; Karlsson, Olle; Inghardt, Tord; Andersson, Kjell

Agent Davies Collison Cave

Pub. Number AU-B-2001256931

PCT Pub. Number WO01/87879

Priority 0001803 16.05.00 SE

Filing date 14 May 2001

Wipo publication date 26 November 2001

Acceptance publication date 4 August 2005

International Classifications

C07D 409/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 205/04 Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

C07D 335/06 Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom

A61P 007/00 Drugs for disorders of the blood or the extracellular fluid

A61K 031/382 - having six-membered rings, e.g. thioxanthenes

A61K 031/397 - having four-membered rings, e.g. azetidine

Event Publications

4 August 2005 Application Accepted

  Published as AU-B-2001256931

1 December 2005 Standard Patent Sealed

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001256932

2001256930